Stay updated with breaking news from Artelo Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Wall Street brokerages predict that Artelo Biosciences, Inc. (NASDAQ:ARTL – Get Rating) will report earnings per share (EPS) of ($0.05) for the current fiscal quarter, according to Zacks. Zero analysts have provided estimates for Artelo Biosciences’ earnings. The company is scheduled to issue its next earnings results on Monday, January 1st. According to Zacks, analysts […]
Wall Street analysts expect that Artelo Biosciences, Inc. (NASDAQ:ARTL – Get Rating) will announce earnings of ($0.06) per share for the current fiscal quarter, according to Zacks. Zero analysts have provided estimates for Artelo Biosciences’ earnings. Artelo Biosciences posted earnings per share of ($0.11) during the same quarter last year, which would indicate a positive […]
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Wall Street analysts forecast that Artelo Biosciences, Inc. (NASDAQ:ARTL – Get Rating) will report earnings per share of ($0.06) for the current quarter, according to Zacks. Zero analysts have made estimates for Artelo Biosciences’ earnings. Artelo Biosciences reported earnings per share of ($0.11) in the same quarter last year, which suggests a positive year over […]
Share this article LAS VEGAS, April 12, 2021 /PRNewswire/ -- The Cancer Anorexia report provides a detailed view of the Cancer Anorexia market forecasts up to 2030, analysis of treatment landscape, promising emerging therapies, changing market landscape, individual market share of pipeline therapies, Cancer Anorexia market drivers, and market barriers, Cancer Anorexia market size during the study period 2018-30 in the 7MM. The Cancer Anorexia Market report is created to uncover authentic opportunities in the Cancer Anorexia market landscape in the 7MM (the US, EU5 (the UK, Germany, Italy, S...